This company seems to have been delisted
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
ViewRay
VRAY
$0.02500
Share price
0.00%
Change (1 day)
-99.27%
Change (1 year)
Categories
Revenue for ViewRay (VRAY)
Revenue in 2023 (TTM): $0.10 Billion USD
According to ViewRay's latest financial reports the company's current revenue (TTM 
) is $0.10 Billion USD. In 2022 the company made a revenue of $0.10 Billion USD an increase over the revenue in the year 2021 that were of $70.11 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for ViewRay from 2014 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.10 B | 3.58% |
| 2022 | $0.10 B | 45.76% |
| 2021 | $70.11 M | 22.98% |
| 2020 | $57.01 M | -35.05% |
| 2019 | $87.78 M | 8.42% |
| 2018 | $80.96 M | 137.83% |
| 2017 | $34.04 M | 53.09% |
| 2016 | $22.23 M | 123.98% |
| 2015 | $9.92 M | |
| 2014 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | $0.10 B | 0.00% | 🇺🇸 USA |
 | $0.82 B | 675.33% | 🇺🇸 USA |
 | $10.68 M | -89.91% | 🇮🇱 Israel |